Presentation is loading. Please wait.

Presentation is loading. Please wait.

Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis by Marcello Di Nisio, Anne W. S. Rutjes, Noemi.

Published byGregory Neal Modified over 8 years ago

Similar presentations

Presentation on theme: "Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis by Marcello Di Nisio, Anne W. S. Rutjes, Noemi."— Presentation transcript:

1 Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis by Marcello Di Nisio, Anne W. S. Rutjes, Noemi Ferrante, Gian Mario Tiboni, Franco Cuccurullo, and Ettore Porreca Blood Volume 118(10):2670-2678 September 8, 2011 ©2011 by American Society of Hematology

2 Flow chart. Marcello Di Nisio et al. Blood 2011;118:2670-2678 ©2011 by American Society of Hematology

3 Forest plot of case-control studies on inherited thrombophilia and assisted reproductive technology. Marcello Di Nisio et al. Blood 2011;118:2670-2678 ©2011 by American Society of Hematology

4 Forest plot of case-control studies on anti-phospholipid antibodies and assisted reproductive technology. Marcello Di Nisio et al. Blood 2011;118:2670-2678 ©2011 by American Society of Hematology

5 Funnel plot of studies on anti-phospholipid antibodies. Marcello Di Nisio et al. Blood 2011;118:2670-2678 ©2011 by American Society of Hematology

6 Forest plot of cohort studies on anti-phospholipid antibodies and outcomes-assisted reproductive technology. Marcello Di Nisio et al. Blood 2011;118:2670-2678 ©2011 by American Society of Hematology

Download ppt "Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis by Marcello Di Nisio, Anne W. S. Rutjes, Noemi."

Similar presentations

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in.

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in.
Trial Identification, Inclusion, and Exclusion Krista M. Dale et al, JAMA. 2006; 295: 74-80.

Trial Identification, Inclusion, and Exclusion Krista M. Dale et al, JAMA. 2006; 295:
DEFINING THE DURATION OF ANTICOAGULATION. HOW LONG TO TREAT A DVT?

DEFINING THE DURATION OF ANTICOAGULATION. HOW LONG TO TREAT A DVT?
Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.
Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome by Jacob H. Rand,

Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome by Jacob H. Rand,
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis by David C. Burgess, Michael.

Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis by David C. Burgess, Michael.
Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients by.

Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients by.
Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus ErythematosusClinical Perspective by.

Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus ErythematosusClinical Perspective by.
Yin-Shuo Chang, MD, Yu-Chen Huang, MD 

Yin-Shuo Chang, MD, Yu-Chen Huang, MD 
The influence of high-altitude living on body iron

The influence of high-altitude living on body iron
Statin Treatment and Functional Outcome After Ischemic Stroke

Statin Treatment and Functional Outcome After Ischemic Stroke
TCR-MHC-peptide(s): in vivo veritas

TCR-MHC-peptide(s): in vivo veritas
Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis  Konstantinos A. Toulis, M.D.,

Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis  Konstantinos A. Toulis, M.D.,
Multiple Myeloma: Interleukin-15 Antagonizes Bone Morphogenetic Protein-Induced Apoptosis and Growth Inhibition. by Magne Rekvig, Anne-Tove Brenne, Torstein.

Multiple Myeloma: Interleukin-15 Antagonizes Bone Morphogenetic Protein-Induced Apoptosis and Growth Inhibition. by Magne Rekvig, Anne-Tove Brenne, Torstein.
Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura

Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura
Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study by Lori-Ann Linkins,

Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study by Lori-Ann Linkins,
Next-generation leukemia immunotherapy

Next-generation leukemia immunotherapy
by Venetia Bigley, Laura E. Spence, and Matthew Collin

by Venetia Bigley, Laura E. Spence, and Matthew Collin
Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study by.

Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study by.

Similar presentations

Ads by Google